{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:38:43Z","timestamp":1792719523897,"version":"4.5.0"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Recent studies have reported a high prevalence of thrombotic events in coronavirus disease 2019. However, the significance of thromboembolic complications has not been widely appreciated. The purpose of this review is to provide current knowledge of this serious problem.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Narrative review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Sources:<\/jats:title>\n            <jats:p>Online search of published medical literature through PubMed using the term \u201cCOVID-19,\u201d \u201cSARS,\u201d \u201cacute respiratory distress syndrome,\u201d \u201ccoronavirus,\u201d \u201ccoagulopathy,\u201d \u201cthrombus,\u201d and \u201canticoagulants.\u201d<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study Selection and Data Extraction:<\/jats:title>\n            <jats:p>Articles were chosen for inclusion based on their relevance to coagulopathy and thrombosis in coronavirus disease 2019, and anticoagulant therapy. Reference lists were reviewed to identify additional relevant articles.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Synthesis:<\/jats:title>\n            <jats:p>Coronavirus disease 2019 is associated with a strikingly high prevalence of coagulopathy and venous thromboembolism that may contribute to respiratory deterioration. Monitoring coagulation variables is important, as abnormal coagulation tests are related to adverse outcomes and may necessitate adjuvant antithrombotic interventions. In the initial phase of the infection, <jats:sc>d<\/jats:sc>-dimer and fibrinogen levels are increased, while activated partial prothrombin time, prothrombin time, and platelet counts are often relatively normal. Increased <jats:sc>d<\/jats:sc>-dimer levels three times the upper limit of normal may trigger screening for venous thromboembolism. In all hospitalized patients, thromboprophylaxis using low-molecular-weight heparin is currently recommended. The etiology of the procoagulant responses is complex and thought to be a result of specific interactions between host defense mechanisms and the coagulation system. Although the coagulopathy is reminiscent of disseminated intravascular coagulation and thrombotic microangiopathy, it has features that are markedly distinct from these entities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Severe acute respiratory syndrome coronavirus 2\/coronavirus disease 2019 frequently induces hypercoagulability with both microangiopathy and local thrombus formation, and a systemic coagulation defect that leads to large vessel thrombosis and major thromboembolic complications, including pulmonary embolism in critically ill hospitalized patients. <jats:sc>d<\/jats:sc>-dimers and fibrinogen levels should be monitored, and all hospitalized patients should undergo thromboembolism prophylaxis with an increase in therapeutic anticoagulation in certain clinical situations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000004458","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T13:53:06Z","timestamp":1590760386000},"page":"1358-1364","source":"Crossref","is-referenced-by-count":433,"title":["Coagulopathy of Coronavirus Disease 2019"],"prefix":"10.1097","volume":"48","author":[{"given":"Toshiaki","family":"Iba","sequence":"first","affiliation":[{"name":"Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Levi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Cardio-metabolic Programme-NIHR UCLH\/UCL BRC, University College London Hospitals NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marie","family":"Connors","sequence":"additional","affiliation":[{"name":"Hematology Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jecko","family":"Thachil","sequence":"additional","affiliation":[{"name":"Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/eurheartj\/ehaa254","article-title":"Acute pulmonary embolism and COVID-19 pneumonia: A random association?.","volume":"41","author":"Danzi","year":"2020","journal-title":"Eur Heart J"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19.","volume":"382","author":"Zhang","year":"2020","journal-title":"N Engl J Med"},{"key":"R3-20230728","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.","author":"Wu","year":"2020 Mar 13. [online ahead of print]","journal-title":"JAMA Intern Med"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"101623","DOI":"10.1016\/j.tmaid.2020.101623","article-title":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.","volume":"34","author":"Rodriguez-Morales","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"R5-20230728","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14854","article-title":"The procoagulant pattern of patients with Covid-19 acute respiratory distress syndrome.","author":"Ranucci","year":"2020 Apr 17. [online ahead of print]","journal-title":"J Thromb Haemost"},{"key":"R6-20230728","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis.","author":"Panigada","year":"2020 Apr 17","journal-title":"J Thromb Haemost"},{"key":"R7-20230728","first-page":"E006","article-title":"Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia.","volume":"41","author":"Zhang","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/22221751.2020.1741327","article-title":"Clinical observation and management of COVID-19 patients.","volume":"9","author":"Li","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","article-title":"Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.","volume":"9","author":"Lin","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"R10-20230728","first-page":"2020020407","article-title":"Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19).","author":"Luo","year":"2020","journal-title":"Preprints"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11684-020-0767-8","article-title":"Coronavirus disease 2019 (COVID-19): A clinical update.","volume":"14","author":"Zhou","year":"2020","journal-title":"Front Med"},{"key":"R12-20230728","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.","author":"Magro","year":"2020 Apr 15","journal-title":"Transl Res"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19.","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood-2017-10-804096","article-title":"How I treat disseminated intravascular coagulation.","volume":"131","author":"Levi","year":"2018","journal-title":"Blood"},{"key":"R15-20230728","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19.","author":"Klok","year":"2020 Apr 10","journal-title":"Thromb Res"},{"key":"R16-20230728","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Lille ICU Haemostasis COVID-19 Group: Pulmonary embolism in COVID-19 patients: Awareness of an increased prevalence.","author":"Poissy","year":"2020 Apr 24","journal-title":"Circulation"},{"key":"R17-20230728","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2020201561","article-title":"Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels.","author":"Leonard-Lorant","year":"2020 Apr 23","journal-title":"Radiology"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"China medical treatment expert group for covid-19. Clinical characteristics of coronavirus disease 2019 in China.","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"R19-20230728","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study.","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"R20-20230728","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.","author":"Zhang","year":"2020 Apr 19. [online ahead of print]","journal-title":"J Thromb Haemost"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study.","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R25-20230728","article-title":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARSCoV2.","author":"Yin","year":"2020 Apr 3","journal-title":"J Thromb Thrombolysis"},{"key":"R26-20230728","first-page":"1","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies.","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"R27-20230728","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14832","article-title":"Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered questions.","author":"Amgalan","year":"2020 Apr 11","journal-title":"J Thromb Haemost"},{"key":"R28-20230728","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000000824","article-title":"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: A retrospective study.","author":"Deng","year":"2020 Mar 20","journal-title":"Chin Med J"},{"key":"R29-20230728","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2020-0188","article-title":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.","author":"Han","year":"2020 Mar 16","journal-title":"Clin Chem Lab Med"},{"key":"R30-20230728","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.047419","article-title":"Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis?.","author":"Campbell","year":"2020 Apr 9","journal-title":"Circulation"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2013-09-526277","article-title":"Multiple roles of the coagulation protease cascade during virus infection.","volume":"123","author":"Antoniak","year":"2014","journal-title":"Blood"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13613-017-0339-5","article-title":"Immunohaemostasis: A new view on haemostasis during sepsis.","volume":"7","author":"Delabranche","year":"2017","journal-title":"Ann Intensive Care"},{"key":"R33-20230728","doi-asserted-by":"crossref","first-page":"e20200652","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: Neutrophil extracellular traps.","volume":"217","author":"Barnes","year":"2020","journal-title":"J Exp Med"},{"key":"R34-20230728","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.12047","article-title":"Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome.","volume":"11","author":"Glas","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R35-20230728","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/ajrccm.161.2.9712038","article-title":"Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome.","volume":"161","author":"G\u00fcnther","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R36-20230728","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1097\/01.CCM.0000057846.21303.AB","article-title":"Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.","volume":"31","author":"Idell","year":"2003","journal-title":"Crit Care Med"},{"key":"R37-20230728","doi-asserted-by":"crossref","first-page":"e00271","DOI":"10.1128\/mBio.00271-13","article-title":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury.","volume":"4","author":"Gralinski","year":"2013","journal-title":"mBio"},{"key":"R38-20230728","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","article-title":"Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility.","volume":"100","author":"Ji","year":"2020","journal-title":"Physiol Rev"},{"key":"R39-20230728","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jclinpath-2020-206522","article-title":"Autopsy in suspected COVID-19 cases.","volume":"73","author":"Hanley","year":"2020","journal-title":"J Clin Pathol"},{"key":"R40-20230728","first-page":"1","article-title":"COVID-19 pneumonia: Different respiratory treatments for different phenotypes?.","volume":"14","author":"Gattinoni","year":"2020","journal-title":"Intensive Care Med"},{"key":"R41-20230728","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19.","author":"Dolhnikoff","year":"2020 Apr 15. [online ahead of print]","journal-title":"J Thromb Haemost"},{"key":"R42-20230728","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target.","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"key":"R43-20230728","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"R44-20230728","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25822","article-title":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis.","author":"Cao","year":"2020 Apr 3. [online ahead of print]","journal-title":"J Med Virol"},{"key":"R45-20230728","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression.","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"R46-20230728","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccc.2019.12.004","article-title":"Coagulation disorders in hemophagocytic lymphohistiocytosis\/macrophage activation syndrome.","volume":"36","author":"Valade","year":"2020","journal-title":"Crit Care Clin"},{"key":"R47-20230728","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.chest.2015.11.004","article-title":"Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis.","volume":"149","author":"Seguin","year":"2016","journal-title":"Chest"},{"key":"R48-20230728","first-page":"e200067","article-title":"COVID-19 complicated by acute pulmonary embolism.","volume":"2","author":"Xie","year":"2020","journal-title":"Radiology: Cardiothoracic Imaging"},{"key":"R49-20230728","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.","author":"Cui","year":"2020 Apr 9. [online ahead of print]","journal-title":"J Thromb Haemost"},{"key":"R50-20230728","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5858\/2004-128-195-AODDTS","article-title":"Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: Challenges in determining a SARS diagnosis.","volume":"128","author":"Chong","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"R51-20230728","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19.","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R52-20230728","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.20.23072","article-title":"Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: A preliminary analysis.","author":"Liu","year":"2020 Mar 18","journal-title":"AJR Am J Roentgenol"},{"key":"R53-20230728","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.03.021","article-title":"Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.","author":"Dashraath","year":"2020 Mar 23","journal-title":"Am J Obstet Gynecol"},{"key":"R54-20230728","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance in recognition and management of coagulopathy or DIC in COVID-19-specific issues for consideration in pregnant women.","volume":"18","author":"Abdul-Kadir","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R55-20230728","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China.","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"R56-20230728","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R57-20230728","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jth.14821","article-title":"The versatile heparin in COVID-19.","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R58-20230728","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jss.2019.01.020","article-title":"Unfractionated heparin alleviates sepsis-induced acute lung injury by protecting tight junctions.","volume":"238","author":"Liu","year":"2019","journal-title":"J Surg Res"},{"key":"R59-20230728","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation.","author":"Connors","year":"2020 Apr 27. [online ahead of print]","journal-title":"Blood"},{"key":"R60-20230728","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/000313480106700417","article-title":"Treatment of severe acute respiratory distress syndrome: A final report on a phase I study.","volume":"67","author":"Hardaway","year":"2001","journal-title":"Am Surg"},{"key":"R61-20230728","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0000000000002694","article-title":"Is there a role for tissue plasminogen activator (tPA) as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome (ARDS).","author":"Moore","year":"2020 Mar 20","journal-title":"J Trauma Acute Care Surg"},{"key":"R62-20230728","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/eci.12168","article-title":"Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.","volume":"43","author":"Hobl","year":"2013","journal-title":"Eur J Clin Invest"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T11:56:00Z","timestamp":1690545360000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000004458","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,28]]}}}